Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v4-FR Version v1-EN
Language French English
Date Updated 2020-09-21 2020-09-18
Drug Identification Number 02387034 02387034
Brand name ADREVIEW ADREVIEW
Common or Proper name Iobenguane (123I) Injection Iobenguane (123I) Injection
Company Name GE HEALTHCARE CANADA INC GE HEALTHCARE CANADA INC
Ingredients IOBENGUANE 123 I IOBENGUANE 123 I
Strength(s) 74MBq 74MBq
Dosage form(s) SOLUTION SOLUTION
Route of administration INTRAVENOUS INTRAVENOUS INTRAVENOUS INTRAVENOUS
Packaging size 5 mL 5 mL
ATC code V09IX V09IX
ATC description
Reason for shortage Disruption of the manufacture of the drug. Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2020-09-15 2020-09-15
Estimated end date 2020-09-20 2020-09-20
Actual end date 2020-09-20
Shortage status Resolved Actual shortage
Tier 3 Status No No
Company comments
Health Canada comments